BATF3 and neoplasm: cDC1 depletion in Batf3-deficient mice impaired the capacity of the mice to reject transplantable immunogenic tumors and led to compromised T-cell-mediated responses to tumor immunotherapy, including ICI treatments [8, 10, 28, 29].